Identification of Predictive Biomarkers for Precision Cancer Medicine with Collective Correlated Nonnegative Matrix Factorization (ccNMF)

Description of the granted funding

The development of human diseases such as cancers involve the complex interactions that regulate entire biological processes. This project aims to improve our understanding of the genomic and molecular mechanisms underlying cancer progression and drug response phenotypes, by developing state-of-the-art machine learning methods for statistical integration of multi-omics data generated from multiple types of cancers. The resulting models will reveal genomic and molecular factors which are predictive of cancer progression and mode-of-action of drug treatments, shedding light on the complex interactions among multiple biological processes underlying the development of human diseases. The proposed methods will be validated using unique datasets profiled in-house at Institute for Molecular Medicine FIMM as well as available from public sources. Importantly, in close collaboration with cancer biologists at FIMM, the most clinically actionable predictions will be validated in the wet lab.
Show more

Starting year

2020

End year

2023

Granted funding

Xiangju Qin Orcid -palvelun logo
289 590 €

Funder

Research Council of Finland

Funding instrument

Postdoctoral Researcher

Other information

Funding decision number

332055

Fields of science

Biomedicine

Research fields

Systeemibiologia, bioinformatiikka

Identified topics

cancer